Technical Analysis for TSVT - 2seventy bio, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Support | Bullish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | -2.98% | |
| 200 DMA Support | Bullish | 0.24% | |
| Hammer Candlestick | Bullish | 0.24% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.24% | |
| NR7 | Range Contraction | 0.24% | |
| Doji - Bullish? | Reversal | 0.24% | |
| BB Squeeze Ended | Range Expansion | 0.24% |
| Alert | Time |
|---|---|
| Fell Below 200 DMA | 2 days ago |
| 200 DMA Support | 2 days ago |
| Fell Below Previous Day's Low | 2 days ago |
| Down 3% | 2 days ago |
| Possible Inside Day | 2 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc. operates independently of bluebird bio, Inc. as of November 4, 2021.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.69 |
| 52 Week Low | 1.535 |
| Average Volume | 817,621 |
| 200-Day Moving Average | 4.17 |
| 50-Day Moving Average | 4.79 |
| 20-Day Moving Average | 4.56 |
| 10-Day Moving Average | 4.41 |
| Average True Range | 0.35 |
| RSI (14) | 42.53 |
| ADX | 10.09 |
| +DI | 22.98 |
| -DI | 23.21 |
| Chandelier Exit (Long, 3 ATRs) | 4.09 |
| Chandelier Exit (Short, 3 ATRs) | 5.09 |
| Upper Bollinger Bands | 5.05 |
| Lower Bollinger Band | 4.06 |
| Percent B (%b) | 0.17 |
| BandWidth | 21.76 |
| MACD Line | -0.13 |
| MACD Signal Line | -0.10 |
| MACD Histogram | -0.0291 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.71 | ||||
| Resistance 3 (R3) | 4.74 | 4.62 | 4.63 | ||
| Resistance 2 (R2) | 4.62 | 4.49 | 4.60 | 4.60 | |
| Resistance 1 (R1) | 4.42 | 4.42 | 4.36 | 4.39 | 4.58 |
| Pivot Point | 4.30 | 4.30 | 4.26 | 4.28 | 4.30 |
| Support 1 (S1) | 4.10 | 4.17 | 4.04 | 4.07 | 3.88 |
| Support 2 (S2) | 3.98 | 4.10 | 3.96 | 3.86 | |
| Support 3 (S3) | 3.78 | 3.98 | 3.83 | ||
| Support 4 (S4) | 3.75 |
